Integrative genome analyses identify key somatic driver mutations of small-cell lung cancerMartin Peifer, Roman K. Thomas|Nature Genetics|2012Cited by 1.4k
Telomerase activation by genomic rearrangements in high-risk neuroblastomaMartin Peifer, Johannes H. Schulte, Falk Hertwig et al.|Nature|2015Cited by 608
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase InhibitionGürkan Mollaoglu, Trudy G. Oliver, Matthew R. Guthrie et al.|Cancer Cell|2017Cited by 607
Comparison of RNA-seq and microarray-based models for clinical endpoint predictionWenqian Zhang, Carolina Rosswog, Tao Qing et al.|Genome Biology|2015Cited by 429
Identifying genotype-dependent efficacy of single and combined PI3K- and MAPK-pathway inhibition in cancerMartin L. Sos, Roman K. Thomas, Stefanie Fischer et al.|Proceedings of the National Academy of Sciences|2009Cited by 255